share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/11/08 13:29

Moomoo AI 已提取核心訊息

On November 7, 2024, HeartSciences Inc., also known as Heart Test Laboratories, held its Annual Meeting of Stockholders, where two key proposals were voted upon. The first proposal was the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025. This proposal was approved with 413,499 votes for, 9,896 against, and 1,116 abstentions. The second proposal addressed the potential adjournment of the Annual Meeting to a later date if necessary to solicit additional proxies in the event of insufficient votes for any proposals. Shareholders approved this adjournment proposal with 367,736 votes for, 18,963 against, and 37,811 abstentions. No other issues were voted on at the meeting. The report was signed by Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board of Directors, on November 8, 2024.
On November 7, 2024, HeartSciences Inc., also known as Heart Test Laboratories, held its Annual Meeting of Stockholders, where two key proposals were voted upon. The first proposal was the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025. This proposal was approved with 413,499 votes for, 9,896 against, and 1,116 abstentions. The second proposal addressed the potential adjournment of the Annual Meeting to a later date if necessary to solicit additional proxies in the event of insufficient votes for any proposals. Shareholders approved this adjournment proposal with 367,736 votes for, 18,963 against, and 37,811 abstentions. No other issues were voted on at the meeting. The report was signed by Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board of Directors, on November 8, 2024.
2024年11月7日,HeartSciences Inc.,也稱爲Heart Test Laboratories,舉行了股東年度大會,就兩項關鍵提案進行了投票。第一項提案是批准Haskell & White LLP爲截至2025年4月30日的財政年度的獨立註冊會計師。該提案獲得了413,499票贊成,9,896票反對,1,116票棄權,獲得通過。第二項提案涉及在必要時將年度大會延期至後續日期以徵求其他代理人,以彌補任何提案得票不足的情況。股東們批准了這個延期提案,獲得了367,736張贊成票,18,963張反對票,37,811票棄權。會議上未有其他問題投票表決。報告於2024年11月8日由董事會主席,總裁兼首席執行官安德魯·辛普森簽署。
2024年11月7日,HeartSciences Inc.,也稱爲Heart Test Laboratories,舉行了股東年度大會,就兩項關鍵提案進行了投票。第一項提案是批准Haskell & White LLP爲截至2025年4月30日的財政年度的獨立註冊會計師。該提案獲得了413,499票贊成,9,896票反對,1,116票棄權,獲得通過。第二項提案涉及在必要時將年度大會延期至後續日期以徵求其他代理人,以彌補任何提案得票不足的情況。股東們批准了這個延期提案,獲得了367,736張贊成票,18,963張反對票,37,811票棄權。會議上未有其他問題投票表決。報告於2024年11月8日由董事會主席,總裁兼首席執行官安德魯·辛普森簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息